Početna stranicaSYK • NYSE
add
Stryker Corp
370,00 $
Poslije radnog vremena:(0,00 %)0,00
370,00 $
Zatvoreno: 14. lis, 16:04:52 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
364,92 $
Dnevni raspon
364,27 $ - 372,95 $
Godišnji raspon
329,16 $ - 406,19 $
Tržišna kapitalizacija
141,45 mlr. USD
Prosječna količina
1,39 mil.
P/E omjer
48,96
Prinos dividende
0,91 %
Glavno tržište vrijednosnica
NYSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Prihod | 6,02 mlr. | 11,07 % |
Operativni troškovi | 2,59 mlr. | 11,87 % |
Neto dohodak | 884,00 mil. | 7,15 % |
Neto profitabilnost | 14,68 | −3,55 % |
Zarada po dionici | 3,13 | 11,39 % |
EBITDA | 1,62 mlr. | 15,00 % |
Efektivna porezna stopa | 12,99 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 2,46 mlr. | 25,91 % |
Ukupna imovina | 46,33 mlr. | 18,40 % |
Ukupne obveze | 25,14 mlr. | 29,80 % |
Ukupni kapital | 21,19 mlr. | — |
Dionice u optjecaju | 382,31 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 6,58 | — |
Povrat imovine | 7,16 % | — |
Povrat kapitala | 8,63 % | — |
Tok novca
Neto promjena novca
(USD) | lip 2025.info | Godišnja promjena |
---|---|---|
Neto dohodak | 884,00 mil. | 7,15 % |
Gotovina od poslovanja | 1,11 mlr. | 75,51 % |
Gotovina iz ulaganja | −104,00 mil. | 11,11 % |
Gotovina iz financiranja | −989,00 mil. | −2,38 % |
Neto promjena novca | 55,00 mil. | 112,06 % |
Slobodan tok novca | 1,02 mlr. | 79,44 % |
Više
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
Glavni izvršni direktor
Osnovano
1941
Web-lokacija
Zaposlenici
53.000